You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

231 Results
Guidelines and Advice
Status: Current
ID: 7-A-2018-3
Feb 2021
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
tislelizumab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Updated
Apr 2026
Guidelines and Advice
Status: Current
ID: 19-4
Version: 2
Updated
Mar 2026

Pages